Molecular predictors of response to chemotherapy in lung cancer

This publication has 19 references indexed in Scilit:

• Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial
  Annals of Oncology, 2002
• Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
  New England Journal of Medicine, 2002
• Loss of heterozygosity of nucleotide excision repair factors in sporadic ovarian, colon and lung carcinomas: implication for their roles of carcinogenesis in human solid tumors
  Cancer Letters, 2001
• P53 plays a protective role against UV- and cisplatin-induced apoptosis in transcription-coupled repair proficient fibroblasts
  Oncogene, 2001
• Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair
  Nature Medicine, 2001
• Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways
  International Journal of Cancer, 2001
• Controlling the efficiency of excision repair
  Mutation Research/DNA Repair, 2001
• Proneness to UV-induced apoptosis in human fibroblasts defective in transcription coupled repair is associated with the lack of Mdm2 transactivation
  Oncogene, 2000
• Inhibition of RNA Polymerase II Transcription in Human Cell Extracts by Cisplatin DNA Damage
  Biochemistry, 1999
• Persistent DNA damage induced by ultraviolet light inhibits p21waf1 and bax expression: implications for DNA repair, UV sensitivity and the induction of apoptosis
  Oncogene, 1998